Albany Molecular Research, Inc. (Nasdaq: AMRI) today
announced the election of Shirley Ann Jackson, Ph.D. to its Board of Directors. This election
fills a newly created position.
A prominent physicist and university president, Dr. Jackson has served since
1999 as president of Rensselaer Polytechnic Institute, one of the nation's
leading technological and research universities, located in Troy, New York.
Before assuming the presidency at Rensselaer, she was chairman of the U.S.
Nuclear Regulatory Commission (NRC) from 1995-1999 under former
President Clinton, and a professor of physics at Rutgers University from 1991
to 1995. Dr. Jackson worked as a theoretical physicist at the former AT&T
Bell Laboratories during the period 1976 to 1991.
"We are delighted to have Dr. Jackson on our Board," said Albany Molecular Research, Inc.
Chairman and Chief Executive Officer Thomas E. D'Ambra, Ph.D. "Dr. Jackson brings a strong
scientific background as a physicist and university administrator, along with extensive experience
in industry, academia and government. She is a visionary leader and driven individual who has
instituted significant change and improvement at Rensselaer. Her wisdom and experience will be
valuable to AMRI."
Soon after assuming leadership at Rensselaer, Dr. Jackson launched a comprehensive and
ambitious strategic plan to enhance research and upgrade Rensselaer's status as a leading
university, particularly in the areas of biotechnology and information technology. D'Ambra
continued, "We think that Rensselaer's strategic focus in biotechnology research, along with
related biotechnology research collaborations between Rensselaer and other university and
government organizations in the Albany area, will provide excellent vehicles to strengthen
academic and industrial ties locally."
Dr. Jackson becomes the seventh member of the AMRI Board of Directors. She received her
undergraduate degree from MIT in physics and a doctorate in theoretical physics from MIT in
1973. For 15 years, Dr. Jackson conducted research in theoretical physics, solid state and
quantum physics, and optical physics at AT"T Bell Laboratories. While Dr. Jackson was a
professor of physics at Rutgers from 1991 to 1995, she also served as a consultant to Bell
Labs. In 1995, Dr. Jackson was appointed by former President Clinton as chairman of the US
Nuclear Regulatory Commission, where she served until her appointment at Rensselaer. While
at the NRC, Dr. Jackson was elected chair of the International Nuclear Regulators Association,
which is composed of senior nuclear regulatory officials from Canada, France, Germany, Japan,
Spain, Sweden, the United Kingdom and the United States. For four years, she represented the
U.S. at the General Conference of the International Atomic Energy Agency in Vienna, Austria.
Dr. Jackson is a member of the National Academy of Engineering and the American Academy
of Arts and Sciences. She is a Life Member of the MIT Corporation (MIT's Board of
Trustees). In addition to her position at AMRI, Dr. Jackson also serves as a director of FedEx
Corporation, AT"T, Public Service Enterprise Group, Sealed Air Corporation, Newport News
Shipbuilding, USX Corporation, and SCI Systems Inc.